MedPath

Evaluation of drugs midazolam and bupivacaine in spinal anaesthesia when mixed together and when fentanyl and bupivacaine mixed together in caeserian section.

Phase 2
Conditions
Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium
Registration Number
CTRI/2022/06/043450
Lead Sponsor
Government Medical College Vadodara
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients undergoing Elective caesarean section under spinal anesthesia.

2.Age 18-40yrs.

3,ASA I andII.

4.Height -150 cm and above

Exclusion Criteria

1.Patients refuse spinal anesthesia; unwilling to participate in study,unable to communicate.

2. Patients with localized skin infection, haemorrhagic diathesis ,neurological involvement/ gross spinal abnormality,severe anemia.

3.Patients with history of drug allergy to Bupivacaine, fentanyl and midazolam.

4.Patients with cardiac, pulmonary,hepatic or renal disorders.

5 Bad obstetric history, obstetric complications in present pregnancy, evidence of foetal compromise and anomalies.

6 Patients physically dependent on narcotics or benzodiazepines.

7.Patients unable to understand Visual analog scale.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
â?¢To evaluate post operative analgesic efficacy of Midazolam and Fentanyl as an adjuvant to Bupivacaine heavy for elective lower segment caesarean section .Timepoint: Time from administration of drug intrathecally till 24hrs.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath